Recent studies described the pathophysiological impact of the upregulation of K2P5.1 in CD4+ and CD8+ T cells on the pathogenesis of autoimmune diseases such as rheumatoid arthritis and multiple sclerosis (Bittner et al., 2010a, 2011). This evidence concerns the gene KCNK5 and multiple sclerosis.